Α-Pyrrolidinopentiophenone
| Clinical data | |
|---|---|
| Other names | α-pyrrolidinovalerophenone, α-PVP, O-2387, β-keto-prolintane, prolintanone, desmethylpyrovalerone |
| Addiction liability | Very high |
| Routes of administration | By mouth, intranasal, inhalation, sublingual, intravenous |
| Drug class | Stimulant; Norepinephrine–dopamine reuptake inhibitor (NDRI) |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Elimination half-life | 2 hours |
| Duration of action | 3–5 hours |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C15H21NO |
| Molar mass | 231.339 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (what is this?) (verify) | |
α-Pyrrolidinopentiophenone (α-PVP), also known as α-pyrrolidinovalerophenone, O-2387, β-keto-prolintane, prolintanone, or desmethylpyrovalerone, colloquially, it is sometimes called flakka or gravel, is a synthetic stimulant of the cathinone class developed in the 1960s that has been sold as a designer drug and often consumed for recreational reasons. α-PVP is chemically related to pyrovalerone and is the ketone analog of prolintane.